| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |